Attributes | Values |
---|
rdf:type
| |
Description
| - Opakované podávání tenofoviru potkanům v dávce 25 mg/kg vedlo ke snížení relativního zastoupení aktivní formy cytochromu P450 v jaterních mikrosomech. Tyto enzymy byly částečně denaturovány na neaktivní formu, tj. cytochrom P420. (cs)
- Repeated administration of higher doses (25 mg/kg) of tenofovir to rats decreases the relative proportion of active liver microsomal cytochrome P450. These enzymes are denaturated to the inactive form of cytochrome (CYPP420).
- Repeated administration of higher doses (25 mg/kg) of tenofovir to rats decreases the relative proportion of active liver microsomal cytochrome P450. These enzymes are denaturated to the inactive form of cytochrome (CYPP420). (en)
|
Title
| - In vivo study of the effect of antiviral acyclic nucleotide phosphonate (R)-9-[2 -(phosphonomethoxy)propyl]adenine (PMPA, tenofovir) and its prodrug tenofovir disoproxil fumarate on rat microsomal cytochrome P450
- In vivo studie vlivu acyklického nukleosidfosfonátu (R)-9-[2-(phosphonomethoxy)propyl]adeninu (PMPA, tenofovir) a jeho prodrug tenofoviru disoproxil fumarátu na potkaní mikrosomální cytochrom P450 (cs)
- In vivo study of the effect of antiviral acyclic nucleotide phosphonate (R)-9-[2 -(phosphonomethoxy)propyl]adenine (PMPA, tenofovir) and its prodrug tenofovir disoproxil fumarate on rat microsomal cytochrome P450 (en)
|
skos:prefLabel
| - In vivo study of the effect of antiviral acyclic nucleotide phosphonate (R)-9-[2 -(phosphonomethoxy)propyl]adenine (PMPA, tenofovir) and its prodrug tenofovir disoproxil fumarate on rat microsomal cytochrome P450
- In vivo studie vlivu acyklického nukleosidfosfonátu (R)-9-[2-(phosphonomethoxy)propyl]adeninu (PMPA, tenofovir) a jeho prodrug tenofoviru disoproxil fumarátu na potkaní mikrosomální cytochrom P450 (cs)
- In vivo study of the effect of antiviral acyclic nucleotide phosphonate (R)-9-[2 -(phosphonomethoxy)propyl]adenine (PMPA, tenofovir) and its prodrug tenofovir disoproxil fumarate on rat microsomal cytochrome P450 (en)
|
skos:notation
| - RIV/68378041:_____/08:00315836!RIV09-AV0-68378041
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(1M0508), Z(AV0Z40550506), Z(AV0Z50390512), Z(MSM6198959216)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68378041:_____/08:00315836
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Tenofovir; PMPA; Cytochrome P450 (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Holý, Antonín
- Zídek, Zdeněk
- Anzenbacher, P.
- Anzenbacherová, E.
- Kmoníčková, Eva
- Potměšil, Petr
- Buchar, Evžen
- Veinlichová, A.
- Nekvindová, J.
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |